Verona Pharma plc(NASDAQ:VRNA) 
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. Its product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 ...
Website: http://www.veronapharma.com
Founded: 2005
Full Time Employees: 33
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 55.38
H 56.48
L 52.93
C 53.90
V 2,073,627
10EMA 53.90
20EMA 53.90
60EMA 53.90
120EMA 53.90
250EMA 53.90